title: [Two cases of thymic carcinoid treated with octreotide long-acting repeatable].
abstract: Thymic carcinoid is a rare disease that accounts for 3.1% of thymic tumors and 1.8-6% of all carcinoid tumors in Japan. Advanced thymic carcinoid has a 5-year survival rate of 28-31%.Compared with carcinoid tumors that arise in other organs, thyroid carcinoid tumors carry a relatively worse prognosis, and the most effective therapeutic strategy is thought to be surgical resection.However, for patients with recurrence and distant metastases, multimodal therapy including radiotherapy and/or chemotherapy is usually applied.No chemotherapy treatment regimen has been established in Japan, although the National Comprehensive Cancer Network Guidelines proposed the application of octreotide long-acting repeatable(LAR).In this report, we present two cases of thymic carcinoid that were treated with octreotide LAR and achieved long-term survival.
authors.affiliation: Dept. of Respiratory Surgery, Fukushima Medical University Hospital.
authors.forename: Naoyuki
authors.initials: N
authors.lastname: Okabe
authors.forename: Takuya
authors.initials: T
authors.lastname: Inoue
authors.forename: Yuzuru
authors.initials: Y
authors.lastname: Watanabe
authors.forename: Satoshi
authors.initials: S
authors.lastname: Muto
authors.forename: Takeo
authors.initials: T
authors.lastname: Hasegawa
authors.forename: Jun
authors.initials: J
authors.lastname: Ohsugi
authors.forename: Mitsunori
authors.initials: M
authors.lastname: Higuchi
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Shio
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Suzuki
mesh_terms: D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D002276:Carcinoid Tumor / Q000188:drug therapy* / Q000601:surgery; D003131:Combined Modality Therapy; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D015282:Octreotide / Q000627:therapeutic use*; D013953:Thymus Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D013997:Time Factors
chemical_list: D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide